From the beginning of the covid-19 pandemic, we have already tested approx. 2,500 patients as part of various research projects.

Despite the ongoing Covid-19 pandemic at the BRG facility, we are still active and with ongoing projects. We maintain constant contact with our patients who are open to participation in new research. In order to maintain appropriate prophylaxis and safety of the conducted projects we perform according to the highest standards, using instructions and procedures of the Ministry of Health, Sanitary-epidemiological station, WHO (World Health Organization) and EMA (European Medicines Agency).

We have already tested approximately 2,500 patients as part of various research projects. The safety of patients is supervised by qualified nurses, laboratory technicians, pharmacists and coordinators as well as recognized medical experts with many years of experience and knowledge. This confirm that our site is effective and efficient and able to provide rapid study start-up for trials research of various therapies even in challenging environment.

Go back

News

Completion of a single-center phase I study of the safety and pharmacokinetics of CPL207280

We have just completed a phase I study of safety and pharmacokinetics (part B) of an innovative therapy that could be used...

Read more …

GcLP quality certificate for laboratory procedures

The BRG Clinical Site received the GcLP quality certificate for laboratory procedures and is in the process of obtaining GMP certification for pharmaceutical procedures.

Read more …

Study for healthy people with a drug against Covid-19

In BRG we are currently performing a study for healthy people with a drug against Covid-19 .
In the project we are comparing experimental injectable drug called...

Read more …

Phase I study finished

Our site has just succesfully finished clinical stage of phase I (two parts) study with JAK kinase inhibitors.

Read more …

Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers

In BRG we are just starting Study for Healthy People with an Immune Drug - Part B. The aim of the following clinical trial...

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲